Company intelligence / Profile preview
Fzata, Inc.
Halethorpe, Maryland, USAfzata.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Fzata’s lead candidate, FZ002, is a first-in-class live biotherapeutic product using engineered yeast to deliver antibodies against C. difficile toxins directly in the gut. The program has completed cGMP manufacturing and entered IND-enabling studies as of 2024. Research on this approach has been published in Science Translational Medicine and demonstrated efficacy in animal models for treating C. diff infection.[3] Other pipeline programs are at preclinical or discovery stages targeting GI disorders and metabolic diseases.[3][6]
- Therapeutic areas
- GastroenterologyEndocrinologyInfectious Diseases
- Modalities
- Live biotherapeutic products (LBP)Bioengineered probiotic yeast medicinesMonoclonal antibodiesBiological products[6][1][5]
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Fzata welcomes collaborations with biotech/pharma firms but no specific major partnerships disclosed as of May 2025.[2]NIH is a significant grant funder.[3]
Beyond the preview
Go deeper on Fzata, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fzata, Inc..